IPO
Asia PE investment hits new high in 2021
A rebound in China-based activity took Asia private equity investment to a record USD 105.3bn in the fourth quarter, ensuring that 2021 represents a new high watermark for the industry.
Biotech player CANbridge drops on debut after $87m HK IPO
CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses on treatments for cancer and rare diseases, lost 27% in value on its Hong Kong trading debut following a HK$685.1 million ($87.8 million) IPO.
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
China IPOs: The star still wanes
Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence
China regulation: Shock and awe
A raft of rules, largely targeting the technology sector, has challenged business cases and thwarted exits in China. It is also contributing to tweaks in investment strategy
PE-backed Delhivery files for India IPO
India-based e-commerce logistics provider Delhivery is looking to raise up to INR74.6 billion ($1 billion) through a domestic IPO that would facilitate partial exits for The Carlyle Group, Fosun Group, SoftBank Vision Fund 1, and Times Internet.
PE-backed Abbisko trades up after $225m Hong Kong IPO
China-based oncology drug developer Abbisko Therapeutics gained nearly 10% on its Hong Kong trading debut following a HK$1.75 billion ($225 million) IPO.
Evergrande EV unit cancels listing, suffers cash crunch
Evergrande New Energy Vehicle (NEV) Group, the Hong Kong-listed electric vehicle unit of troubled Chinese real estate developer Evergrande has canceled a planned secondary listing on Shanghai's Star Market and warned investors of a cash shortage.
China's Ximalaya abandons US IPO
Ximalaya, a Chinese online audio platform backed by the likes of Tencent Holdings, General Atlantic, and Goldman Sachs, has canceled its planned IPO.
Apax-owned Healthium Medtech files for India IPO
Apax Partners-owned Helthium Medtech, an India-based medical devices manufacturer formerly known as Sutures India, has filed for a domestic IPO.
China launches Beijing Stock Exchange
China has set up its first new bourse since the Shanghai and Shenzhen exchanges in 1990. Beijing Stock Exchange is expected to facilitate exits for small to medium-sized enterprises (SMEs).
China's ANE Logistics files for Hong Kong IPO
ANE Logistics, a Chinese road freight transportation business backed by Centurium Capital, CDH Investments, and CPE among others, has filed for a Hong Kong IPO.
3Q analysis: Guarded reengagement
Fundraising focus shifts to China venture, but it’s the same polarization story; upturn in trade and secondary sales suggests the COVID-19 freeze is thawing; healthcare retains its investment appeal
India allows weighted voting rights in domestic IPOs
Founders, promoters and private equity investors in Indian companies will be able to pursue domestic IPOs with superior voting rights following amendments to existing regulations.
4Q analysis: On trend
The last three months of 2019 were consistent with the preceding nine as pan-regional fundraising remained weak and exits continued to disappoint. Only investment rebelled against the status quo
Carlyle backs Chinese apartment operator Anxin
The Carlyle Group has acquired a significant minority stake in Anxin Apartment, a Chinese serviced apartment operator that specializes in affordable housing for corporate clients.
Chinese drone maker EHang raises $40m in US IPO
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
Hong Kong’s AMTD trades up after US IPO
Shares in AMTD International, a PE-backed division of Hong Kong financial advisor AMTD Group, traded as much as 28% above initial pricing following a $174 million IPO on the New York Stock Exchange.
China-US trade: Suboptimal outcomes
The China-US trade war appears set to enter new territory as legislators contemplate financial sector clampdowns including stock exchange listing restrictions. Investors are bracing for the worst
India secondaries: Mixed signals
India has skirted around an expected boom in secondaries activity for the past couple of years, but investors haven’t lost faith in the narrative’s eventual unfolding. The devil will be in the details
PE-backed ESR postpones Hong Kong IPO
Pan-Asian logistics and fund management platform ESR has postponed its Hong Kong IPO, which was expected to raise up to HK$9.75 billion ($1.24 billion) and facilitate partial exits for several private equity investors.